Form D · Biotechnology
Pocared Diagnostics, Ltd.
Rehovot, L3 · CIK 0001851730
Offering snapshot reported Mar 19, 2021 · SEC filing
- Reported sold
- $2.51M Offering amount: $5M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 1, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2021 | Initial | $2,505,000 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $277K
- Form D file number
- 021-392881
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Aegis Capital Corp | 15007 |
Source: Form D, filed Mar 19, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zvika Blutstein | Executive |
| Ellen Cunniff | Executive |
| Jonathan Gurfinkel | Director, Executive |
| Meir Hadar | Director |
| Gal Ingber | Executive |
| Eduard J. Ludwig | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3 Haim Pekeris Street, Rabin Park
Rehovot, L3, 7670203
Rehovot, L3, 7670203